Various GABA-mimetic drugs differently affect cocaine-evoked hyperlocomotion and sensitization

European Journal of Pharmacology

Volumn 541, Issue 3, 2006, Pages 163-170

  Filip, Małgorzata ^a   Frankowska, Małgorzata ^a   Gołda, Anna ^a   Zaniewska, Magdalena ^a   Vetulani, Jerzy ^a   Przegaliński, Edmund ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

(Rat); Behavioral sensitization; Cocaine; GABA neurotransmission; Locomotor activation

Indexed keywords

4 AMINOBUTYRATE AMINOTRANSFERASE INHIBITOR; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID DERIVATIVE; 4 AMINOBUTYRIC ACID RECEPTOR BLOCKING AGENT; COCAINE; GABAPENTIN; TIAGABINE; VIGABATRIN;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; COCAINE DEPENDENCE; DOSE RESPONSE; GABAERGIC TRANSMISSION; HYPERACTIVITY; LOCOMOTION; MALE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

AMINES; ANIMALS; BEHAVIOR, ANIMAL; BRAIN; COCAINE; COCAINE-RELATED DISORDERS; CYCLOHEXANECARBOXYLIC ACIDS; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; GABA AGENTS; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; MALE; MOTOR ACTIVITY; NIPECOTIC ACIDS; RATS; RATS, WISTAR; VIGABATRIN;

EID: 33745286511     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.05.011     Document Type: Article

References (78)

1. Abdul-Ghani A.S., Norris P.J., Smith C.C., and Bradford H.F. Effects of gamma-acetylenic GABA and gamma-vinyl GABA on synaptosomal release and uptake of GABA. Biochem. Pharmacol. 30 (1981) 1203-1209
2. Andrews C.M., and Lucki I. Effects of cocaine on extracellular dopamine and serotonin levels in the nucleus accumbens. Psychopharmacology 155 (2001) 221-229
3. Ashby Jr. C.R., Rohatgi R., Ngosuwan J., Borda J., Gerasimov M.R., Morgan A.E., Kushner S., Brodie J.D., and Dewey S.L. Implication of the GABA(B) receptor in gamma vinyl-GABA's inhibition of cocaine-induced increases in nucleus accumbens dopamine. Synapse 31 (1999) 151-153
4. Barrett A.C., Negus S.S., Mello N.K., and Caine S.B. Effect of GABA agonists and GABA-A receptor modulators on cocaine- and food-maintained responding and cocaine discrimination in rats. J. Pharmacol. Exp. Ther. 315 (2005) 858-871
5. Berger S.P., Winhusen T.M., Somoza E.C., Harrer J.M., Mezinskis J.P., Leiderman D.B., Montgomery M.A., Goldsmith R.J., Bloch D.A., Singal B.M., and Elkashef A. A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence. Addiction 100 Suppl. 1 (2005) 58-67
6. Bisaga A., Aharonovich E., Garawi F., Levin F.R., Riubin E., Raby W.N., and Nunes E.V. A randomized placebo-controlled trial of gabapentin for cocaine dependence. Drug Alcohol Depend. 81 (2006) 267-274
7. Bohlen P., Huot S., and Palfreyman M.G. The relationship between GABA concentrations in brain and cerebrospinal fluid. Brain Res. 167 (1979) 297-305
8. Boudreau A.C., and Wolf M.E. Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J. Neurosci. 25 (2005) 9144-9151
9. Broderick P.A., Olabisi O.A., Rahni D.N., and Zhou Y. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies. Prog. Neuro-psychopharmacol. Biol. Psychiatry 28 (2004) 547-557
10. Brodie J.D., Figueroa E., Laska E.M., and Dewey S.L. Safety and efficacy of gamma-vinyl GABA (GVG) for the treatment of methamphetamine and/or cocaine addiction. Synapse 55 (2005) 122-125
11. Churchill L., Dilts R.P., and Kalivas P.W. Autoradiographic localization of gamma-aminobutyric acidA receptors within the ventral tegmental area. Neurochem. Res. 17 (1992) 101-106
12. Dahlstro{double acute}m A., and Fuxe K. Localization of monoamines in the lower brain stem. Experientia 20 (1964) 398-399
13. De Vries T.J., Schoffelmeer A.N., Binnekade R., Mulder A.H., and Vanderschuren L.J. Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. Eur. J. Neurosci. 10 (1998) 3565-3571
14. Dewey S.L., Morgan A.E., Ashby Jr. C.R., Horan B., Kushner S.A., Logan J., Volkow N.D., Fowler J.S., Gardner W.L., and Brodie J.D. A novel strategy for the treatment of cocaine addiction. Synapse 30 (1998) 119-129
15. Dhar T.G., Borden L.A., Tyagarajan S., Smith K.E., Branchek T.A., Weinshank R.L., and Gluchowski C. Design, synthesis and evaluation of substituted triarylnipecotic acid derivatives as GABA uptake inhibitors: identification of a ligand with moderate affinity and selectivity for the cloned human GABA transporter GAT-3. J. Med. Chem. 37 (1994) 2334-2342
16. Di Chiara G. The role of dopamine in drug abuse viewed from the perspective of its role in motivation. Drug Alcohol Depend. 38 (1995) 95-137
17. Di Ciano P., and Everitt B.J. The GABA(B) receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmacology 28 (2003) 510-518
18. Eckstein-Ludwig U., Fei J., and Schwarz W. Inhibition of uptake, steady-state currents, and transient charge movements generated by the neuronal GABA transporter by various anticonvulsant drugs. Br. J. Pharmacol. 128 (1999) 92-102
19. Filip M., and Siwanowicz J. Implication of the nucleus accumbens shell, but not core, in the acute and sensitizing effects of cocaine in rats. Pol. J. Pharmacol. 53 (2001) 459-466
20. 2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses. J. Pharmacol. Exp. Ther. 310 (2004) 1246-1254
21. Fink K., Meder W., Dooley D.J., and Go{double acute}thert M. Inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. Br. J. Pharmacol. 130 (2000) 900-906
22. Fink-Jensen A., Suzdak P.D., Swedberg M.D., Judge M.E., Hansen L., and Nielsen P.G. The gamma-aminobutyric acid (GABA) uptake inhibitor, tiagabine, increases extracellular brain levels of GABA in awake rats. Eur. J. Pharmacol. 220 (1992) 197-201
23. B receptor agonist baclofen attenuate cocaine-seeking behavior in rats. Pol. J. Pharmacol. 56 (2004) 240 (Suppl.)
24. Gardner E.L., Schiffer W.K., Horan B.A., Highfield D., Dewey S.L., Brodie J.D., and Ashby Jr. C.R. Gamma-vinyl GABA, an irreversible inhibitor of GABA transaminase, alters the acquisition and expression of cocaine-induced sensitization in male rats. Synapse 46 (2002) 240-250
25. Gasior M., Ungard J.T., and Witkin J.M. Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures. J. Pharmacol. Exp. Ther. 290 (1999) 1148-1156
26. Gee N.S., Brown J.P., Dissanayake V.U., Offord J., Thurlow R., and Woodruff G.N. The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel. J. Biol. Chem. 271 (1996) 5768-5776
27. Gerasimov M.R., Schiffer W.K., Brodie J.D., Lennon I.C., Taylor S.J., and Dewey S.L. Gamma-aminobutyric acid mimetic drugs differentially inhibit the dopaminergic response to cocaine. Eur. J. Pharmacol. 395 (2000) 129-135
28. Goeders N.E., McNulty M.A., Goeders N.E., McNulty M.A., Mirkis S., and McAllister K.H. Chlordiazepoxide alters intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 33 (1989) 859-866
29. Goeders N.E., McNulty M.A., and Guerin G.F. Effects of alprazolam on intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 44 (1993) 471-474
30. Golan H., and Grossman Y. Block of glutamate decarboxylase decreases GABAergic inhibition at the crayfish synapses: possible role of presynaptic metabotropic mechanisms. J. Neurophysiol. 75 (1996) 2089-2098
31. Gołda A., Frankowska M., Filip M., Wydra K., and Przegaliński E. Role of GABA-ergic neurotransmission in the discriminative stimulus effects of cocaine in rats. Pharmacol. Reprod. 57 (2005) S.277-S.278
32. Goldlust A., Su T.Z., Welty D.F., Taylor C.P., and Oxender D.L. Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA. Epilepsy Res. 22 (1995) 1-11
33. Gonzalez G., Sevarino K., Sofuoglu M., Poling J., Oliveto A., Gonsai K., George T.P., and Kosten T.R. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction 98 (2003) 1625-1632
34. Gotz E., Feuerstein T.J., Lais A., and Meyer D.K. Effects of gabapentin on release of gamma-aminobutyric acid from slices of rat neostriatum. Arzneimittelforschung 43 (1993) 636-638
35. Hart C.L., Ward A.S., Collins E.D., Haney M., and Foltin R.W. Gabapentin maintenance decreases smoked cocaine-related subjective effects, but not self-administration by humans. Drug Alcohol Depend. 73 (2004) 279-287
36. Hensch T.K., Fagiolini M., Mataga N., Stryker M.P., Baekkeskov S., and Kash S.F. Local GABA circuit control of experience-dependent plasticity in developing visual cortex. Science 282 (1998) 1504-1508
37. Itzhak Y., and Martin J.L. Effect of riluzole and gabapentin on cocaine- and methamphetamine-induced behavioral sensitization in mice. Psychopharmacology 151 (2000) 226-233
38. Jayaram P., and Steketee J.D. Effects of cocaine-induced behavioural sensitization on GABA transmission within rat medial prefrontal cortex. Eur. J. Neurosci. 21 (2005) 2035-2039
39. Jung M.J., Lippert B., Metcalf B.W., Bohlen P., and Schechter P.J. Gamma-vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J. Neurochem. 29 (1977) 797-802
40. Jung B.J., Dawson Jr. R., Sealey S.A., and Peris J. Endogenous GABA release is reduced in the striatum of cocaine-sensitized rats. Synapse 34 (1999) 103-110
41. Kalivas P.W., Duffy P., and Eberhardt H. Modulation of A10 dopamine neurons by gamma-aminobutyric acid agonists. J. Pharmacol. Exp. Ther. 253 (1990) 858-866
42. Kalivas P.W., Churchill L., and Klitenick M.A. GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience 57 (1993) 1047-1060
43. Kalivas P.W., Pierce R.C., Cornish J., and Sorg B.A. A role for sensitization in craving and relapse in cocaine addiction. J. Psychopharmacol. 12 (1998) 49-53
44. Ke Y., Streeter C.C., Nassar L.E., Sarid-Segal O., Hennen J., Yurgelun-Todd D.A., Awad L.A., Rendall M.J., Gruber S.A., Nason A., Mudrick M.J., Blank S.R., Meyer A.A., Knapp C., Ciraulo D.A., and Renshaw P.F. Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res. 130 (2004) 283-293
45. Kelly K.M. Gabapentin. Antiepileptic mechanism of action. Neuropsychobiology 38 (1998) 139-144
46. Koob G.F. Circuits, drugs, and drug addiction. Adv. Pharmacol. 42 (1998) 978-982
47. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001) 97-129
48. Kusher S.A., Dewey S.L., and Kornetsky C. Gamma-vinyl GABA attenuates cocaine-induced lowering of brain stimulation reward thresholds. Psychopharmacology 133 (1997) 383-388
49. Kusher S.A., Dewey S.L., and Kornetsky C. The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats. J. Pharmacol. Exp. Ther. 290 (1999) 797-802
50. Leach J.P., Sills G.J., Majid A., Butler E., Carswell A., Thompson G.G., and Brodie M.J. Effects of tiagabine and vigabatrin on GABA uptake into primary cultures of rat cortical astrocytes. Seizure 5 (1996) 229-234
51. Lile J.A., Stoops W.W., Glaser P.E., Hays L.R., and Rush C.R. Acute administration of the GABA reuptake inhibitor tiagabine does not alter the effects of oral cocaine in humans. Drug Alcohol Depend. 76 (2004) 81-91
52. Lippert B., Metcalf B.W., Jung M.J., and Casara P. 4-Amino-hex-5-enoic acid, a selective catalytic inhibitor of 4-aminobutyric-acid aminotransferase in mammalian brain. Eur. J. Biochem. 74 (1977) 441-445
53. Loscher W., Jackel R., and Muller F. Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model. Eur. J. Pharmacol. 163 (1989) 1-14
54. Maneuf Y.P., and McKnight A.T. Block by gabapentin of the facilitation of glutamate release from rat trigeminal nucleus following activation of protein kinase C or adenylyl cyclase. Br. J. Pharmacol. 134 (2001) 237-240
55. Meshul C.K., Noguchi K., Emre N., and Ellison G. Cocaine-induced changes in glutamate and GABA immunolabeling within rat habenula and nucleus accumbens. Synapse 30 (1998) 211-220
56. Morgan A.E., and Dewey S.L. Effects of pharmacologic increases in brain GABA levels on cocaine-induced changes in extracellular dopamine. Synapse 28 (1998) 60-65
57. Munzar P., Kutkat S.W., Miller C.R., and Goldberg S.R. Failure of baclofen to modulate discriminative-stimulus effects of cocaine and methamphetamine in rats. Eur. J. Pharmacol. 408 (2000) 169-174
58. Neal M.J., Cunningham J.R., Shah M.A., and Yazulla S. Immunocytochemical evidence that vigabatrin in rats causes GABA accumulation in glial cells of the retina. Neurosci 98 (1989) 29-32
59. Negus S.S., Mello N.K., and Fivel P.A. Effects of GABA agonists and GABA-A receptor modulators on cocaine discrimination in rhesus monkeys. Psychopharmacology 152 (2000) 398-407
60. Neisewander J.L., O'Dell L.E., and Redmond J.C. Localization of dopamine receptor subtypes occupied by intra-accumbens antagonists that reverse cocaine-induced locomotion. Brain Res. 671 (1995) 201-212
61. Palfreyman M.G., Schechter P.J., Buckett W.R., Tell G.P., and Koch-Weser J. The pharmacology of GABA-transaminase inhibitors. Biochem. Pharmacol. 30 (1981) 817-824
62. Petroff O.A., and Rothman D.L. Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin. Mol. Neurobiol. 16 (1998) 97-121
63. Pierce R.C., and Kalivas P.W. A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants. Brain Res. - Brain Res. Rev. 25 (1997) 192-216
64. Pierce R.C., Bell K., Duffy P., and Kalivas P.W. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J. Neurosci. 16 (1996) 1550-1560
65. 1B receptor ligands on cocaine sensitization in rats. Behav. Pharmacol. 12 (2001) 109-116
66. Raby W.N., and Coomaraswamy S. Gabapentin reduces cocaine use among addicts from a community clinic sample. J. Clin. Psychiatry 65 (2004) 84-86
67. Ritz M.C., Cone E.J., and Kuhar M.J. Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. Life Sci. 46 (1990) 635-645
68. Roberts D.C., Andrews M.M., and Vickers G.J. Baclofen attenuates the reinforcing effects of cocaine in rats. Neuropsychopharmacology 15 (1996) 417-423
69. Robinson T.E., and Berridge K.C. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. - Brain Res. Rev. 18 (1993) 247-291
70. Robinson T.E., and Berridge K.C. Incentive-sensitization and addiction. Addiction 96 (2001) 103-114
71. Smith M.A., Yancey D.L., Morgan D., Liu Y., Froestl W., and Roberts D.C. Effects of positive allosteric modulators of the GABAB receptor on cocaine self-administration in rats. Psychopharmacology 173 (2004) 105-111
72. Sorg B.A., Guminski B.J., Hooks M.S., and Kalivas P.W. Cocaine alters glutamic acid decarboxylase differentially in the nucleus accumbens core and shell. Brain Res. - Mol. Brain Res. 29 (1995) 381-386
73. Stro{double acute}mberg M.F., Mackler S.A., Volpicelli J.R., O'Brien C.P., and Dewey S.L. The effect of gamma-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat. Pharmacol. Biochem. Behav. 68 (2001) 291-299
74. Sweatt A.J., Garcia-Espinosa M.A., Wallin R., and Hutson S.M. Branched-chain amino acids and neurotransmitter metabolism: expression of cytosolic branched-chain aminotransferase (BCATc) in the cerebellum and hippocampus. J. Comp. Neurol. 477 (2004) 360-370
75. Tian N., Petersen C., Kash S., Baekkeskov S., Copenhagen D., and Nicoll R. The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 12911-12916
76. Waniewski R.A., and Mertin D.L. Repeated administration of gamma-vinyl-GABA reduces rat brain glutamine synthetase activity. J. Neurochem. 65 (1995) 355-362
77. Winhusen T.M., Somoza E.C., Harrer J.M., Mezinskis J.P., Montgomery M.A., Goldsmith R.J., Coleman F.S., Bloch D.A., Leiderman D.B., Singal B.M., Berger P., and Elkashef A. A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction 100 Suppl. 1 (2005) 68-77
78. Xi Z.X., Ramamoorthy S., Shen H., Lake R., Samuvel D.J., and Kalivas P.W. GABA transmission in the nucleus accumbens is altered after withdrawal from repeated cocaine. J. Neurosci. 23 (2003) 3498-3505